MASI Learn · Public regimen map, Rx boundary and catalog-honest stack
What is David Sinclair’s “anti-aging regimen” — and which parts are medicines vs lifestyle vs supplements? Public interviews and lectures usually mix three layers that customers collapse into one shopping list: (1) lifestyle levers (protein-aware plant-forward eating, meal timing, exercise, sleep), (2) prescription research drugs such as metformin and rapamycin that belong only under a clinician, and (3) consumer longevity molecules such as NMN and resveratrol that MASI actually sells.123456718
This guide answers the regimen question first, keeps a hard prescription boundary, separates human evidence from mechanism and media signal, and places a catalog-honest MASI program next to lifestyle — Premium NMN → meal-timed Premium Resveratrol, with optional Spermidine, Premium Fisetin and Hair Complex by goal.891024
Educational longevity content — not medical advice, not a clinician–patient relationship, and not affiliation with Dr. Sinclair or his institutions. MASI does not sell metformin, rapamycin, low-dose aspirin protocols, prescription “anti-aging” drugs, compounded stacks or clinical services.
Direct answer
- Public signal: Sinclair-era longevity media often discusses a multi-layer personal interest stack — lifestyle first, research drugs in clinical context, and NAD+/sirtuin-related molecules such as NMN and resveratrol. That is communication and research narrative, not a randomized trial of “copy this exact pill tray for every adult.”110111823
- Hard Rx boundary: Metformin and rapamycin are prescription medicines. Evidence of aging interest does not convert them into MASI catalog items or DIY biohacks. Do not source, dose or stack them from this page.45671214162122
- What human evidence supports for consumer molecules: NAD+ biology is central to cellular energy metabolism; human NMN pilots include metabolic/insulin-sensitivity signals in selected adults; resveratrol has short human energy-metabolism work and long mechanistic literature. These support a careful supplement layer — not disease treatment claims.1231015192024
- What to do first: Sleep, resistance training, plant-forward protein adequacy and lower ultra-processed density still dominate healthspan levers. Supplements sit after — not instead of — those basics.111317
- MASI’s honest role: We sell named catalog longevity supplements with path-only product links. We do not sell Sinclair’s private protocol, metformin, rapamycin or “key meds” kits.
Program snapshot: Fix sleep timing and resistance training 2–4×/week. Keep a plant-forward, protein-aware plate. Then use Premium NMN daily and Premium Resveratrol with a fat-containing meal. Add Spermidine or Premium Fisetin for broader cellular goals; use Hair Complex when hair is a primary outcome. Leave prescription aging-research drugs to clinicians. Reassess energy, training progress, waist and clinician labs by day 90.
Affiliation and catalog boundary: MASI Longevity Science is independent and not endorsed by Dr. Sinclair or his institutions. This page explains how public “regimen” talk maps onto lifestyle, prescription research and consumer supplements. It is educational product guidance — not a biography of his medicine cabinet, not personal medical advice, and not a clinician–patient relationship.
Why “key meds” pages mislead shoppers
Search demand for Sinclair’s regimen usually means: tell me the exact pills so I can buy the same outcome. That framing collapses legal class, evidence class and commerce class into one list. A clinically useful page does the opposite — it ranks layers so customers know what belongs in a kitchen, what belongs in a pharmacy under supervision, and what belongs in a longevity supplement cart.
A better adult question is: which levers can I execute safely this week, which require a doctor, and which MASI products honestly fit after the basics?
Three layers of a public longevity regimen
1. Lifestyle levers
Meal quality and timing, protein for muscle after 40, resistance training, aerobic capacity, sleep regularity and lower ultra-processed load. These remain the highest-leverage, lowest-confusion moves for most adults.111317
2. Prescription research drugs
Metformin (diabetes standard of care with aging-interest research) and rapamycin/sirolimus (mTOR inhibitor with geroscience interest and material risks) sit here. They are not MASI products and must not be self-prescribed from SEO content.456712141621
3. Consumer longevity molecules
NMN supports NAD+ precursor pathways; resveratrol is a polyphenol studied for energy-metabolism and sirtuin-related biology; spermidine and fisetin add autophagy/senescence research context. This is MASI’s catalog lane.12389202324
What “public regimen” is not
It is not a guarantee of biological age reversal, not a substitute for indicated disease therapy, and not a license to import foreign prescription drugs because a podcast mentioned them.1718
Prescription layer: education only
Customers keep asking about metformin and rapamycin because longevity media talks about them. Education is allowed; selling cosplay is not.
| Agent (not sold by MASI) | What it is | Evidence flavor people cite | Practical reading for shoppers |
|---|---|---|---|
| Metformin | Biguanide prescription medicine primarily for type 2 diabetes | Long diabetes outcomes literature; observational longevity interest; geroscience proposals treating metformin as a research tool for aging biology | If you do not have a clinician managing it for an approved indication, do not start it from a blog4512 |
| Rapamycin / sirolimus | mTOR-pathway immunosuppressant / transplant medicine class with intermittent aging-research interest | Strong preclinical lifespan literature; human immune-aging exploratory TORC1 inhibition work; safety, metabolic and infection considerations matter | Specialist medical decision only — not a “stack with NMN” internet product6714162122 |
| Other Rx names in longevity chatter | Variable (statins, SGLT2 inhibitors, etc. when discussed for cardiometabolic aging) | Indication-specific outcome trials — not “anti-aging SKUs” | Stay inside your clinician’s indication and monitoring plan17 |
Boundary in plain language: if a molecule requires a prescription, monitoring labs or infection-risk counseling, it is outside MASI commerce. We will not soft-sell it as a missing cart item.
Consumer layer MASI can own honestly
Premium NMN
Supports NAD+ pathways tied to cellular energy metabolism. Human pilot data include muscle insulin-sensitivity signals in selected postmenopausal women with prediabetes-range physiology — useful calibration, not a diabetes drug claim.1210151924
Premium Resveratrol
A polyphenol used with a fat-containing meal in MASI programs. Short human metabolic work and extensive mechanism literature exist; food quality and training still come first.320
Spermidine
Linked to autophagy and cellular maintenance research. Optional after foundation when broader cellular goals matter.8
Premium Fisetin & Hair Complex
Fisetin is studied in senescence biology; Hair Complex is for hair-primary goals. Neither replaces medical care or prescription therapy.9
| Decision | What “good” usually looks like | Evidence flavor | Practical reading |
|---|---|---|---|
| Foundation lifestyle | Sleep window, resistance work, plant-forward protein, lower UPF | Intermittent-fasting reviews; CALERIE calorie-restriction cardiometabolic outcomes; aging therapeutics frameworks111317 | Do this before debating obscure Rx stacks |
| NAD+ support | Daily Premium NMN if a cellular energy layer fits | NAD+ reviews; NMN insulin-sensitivity pilot; NMN intermediate biology12101924 | Complement — not a metformin substitute |
| Polyphenol meal pairing | Premium Resveratrol with dietary fat | Human energy-metabolism resveratrol work; classic in vivo resveratrol review320 | Timing with food beats empty-stomach folklore wars |
| Optional cellular breadth | Spermidine and/or fisetin by goal | Autophagy and senescence literature89 | Add after foundation, not as Rx cosplay |
| Prescription aging interest | Clinician-only if medically appropriate | Metformin aging-tool framing; rapamycin lifespan and TORC1 human exploratory work4671416 | Outside MASI cart forever |
How NMN and resveratrol relate to the “Sinclair stack” story
NAD+ biology sits at the center of cellular energy and stress-response research; restoring precursor availability is a major geroscience theme. NMN is one precursor route studied in humans at pilot scale. Resveratrol is often discussed alongside sirtuin and energy-sensing biology — useful context for why the pair appears together in public regimens, not proof that capsules recreate a celebrity’s full medical chart.1231019202324
MASI’s commercial answer stays narrow: high-purity named products, clear roles, no invented Rx hybrids.
90-day implementation plan
- Days 1–14 — basics first: Fix a consistent sleep window. Start or restart 2 resistance sessions/week. Make plates plant-forward with a clear protein anchor. Write down every prescription you already take and do not add internet “longevity meds.”
- Days 15–45 — catalog foundation: Add Premium NMN daily and Premium Resveratrol with a fat-containing meal. Keep training progressive. If a clinician manages diabetes or other conditions, keep them in the loop before any new supplement.
- Days 46–90 — personalize without Rx cosplay: Optionally add Spermidine or Premium Fisetin. Use Hair Complex if hair is a primary outcome. Reassess energy, strength, waist and clinician labs. Still no self-started metformin or rapamycin.
Best-fit MASI program for this intent: lifestyle honesty first, then cellular foundation with NMN + resveratrol. Browse the full stack at Premium Longevity Supplements. For research context see the Sinclair research map; for food patterns see the longevity diet guide.
Safety after the recommendation
- Prescription drugs named on this page: metformin, rapamycin/sirolimus and any other Rx agents discussed in longevity media are not MASI products. Do not buy, import or dose them from SEO content. Risks can include GI effects and rare serious metabolic complications in metformin contexts, infection/immunosuppression and metabolic trade-offs for mTOR inhibitors, drug–drug interactions and off-label monitoring burdens.46712141621
- Diabetes, CKD, liver disease, transplant, cancer care, pregnancy, breastfeeding: individual medical care beats any public regimen map.
- Polypharmacy: if you take anticoagulants, immunosuppressants, diabetes medicines or multiple chronic therapies, review supplements with a clinician or pharmacist.
- Supplements: NMN, resveratrol, spermidine and fisetin are not medicines and do not diagnose, treat, cure or prevent disease. They are not substitutes for indicated prescription therapy.
- Emergency symptoms: chest pain, severe infection signs, unexplained hypoglycemia, allergic reactions or acute illness need urgent medical care — not a stack adjustment.
FAQ
What does David Sinclair take for anti-aging?
Public discussion usually mixes lifestyle practices, research interest in NAD+/polyphenol molecules such as NMN and resveratrol, and sometimes prescription agents discussed in aging science. Public commentary is not your prescription and not MASI medical advice.11018
Does MASI sell metformin or rapamycin?
No. MASI does not sell metformin, rapamycin/sirolimus, compounded “anti-aging” prescriptions or clinical services. Our catalog is consumer longevity supplements such as Premium NMN and Premium Resveratrol.
Is metformin proven to reverse aging in healthy people?
Metformin has strong evidence in type 2 diabetes care and ongoing scientific interest as a research tool in aging biology. That is not the same as a consumer anti-aging indication or a green light to self-medicate.4512
Can I stack rapamycin with NMN because a podcast said so?
No responsible consumer protocol starts there. Rapamycin-class drugs have meaningful risk profiles and require medical governance. NMN is a separate supplement decision and does not authorize Rx stacking.67141621
What should I buy from MASI if I care about this regimen topic?
Start with Premium NMN and meal-timed Premium Resveratrol after lifestyle basics. Add spermidine, fisetin or Hair Complex by goal. Skip any fantasy that we sell “Sinclair’s meds.”
Is this Dr. Sinclair’s official protocol?
No. This is independent MASI education on how public regimen talk maps to lifestyle, prescription research and catalog products — not a biography, endorsement or clinical relationship.
Related MASI reading
- Sinclair research: insights and challenges
- What does David Sinclair eat? Longevity diet map
- Breakfast and meal timing map
- Meat, protein and longevity patterns
- Sugar and longevity diet guide
- NMN pillar · Resveratrol pillar · Spermidine pillar · Fisetin pillar
Start the catalog-honest program
Keep prescription aging-research drugs with clinicians. Build lifestyle first, then support cellular longevity pathways with products MASI actually sells.
Educational content from MASI Longevity Science. Not medical advice. Not affiliated with or endorsed by Dr. David Sinclair. MASI does not sell metformin, rapamycin or other prescription medicines.
References
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. PubMed 33353981.
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. PubMed 33888596.
- Timmers S, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. PubMed 22055504.
- Barzilai N, et al. Metformin as a tool to target aging. PubMed 27304507.
- Bannister CA, et al. Can people with type 2 diabetes live longer than those without? Metformin vs sulphonylurea mortality comparison. PubMed 25041462.
- Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. PubMed 19587680.
- Mannick JB, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. PubMed 29997249.
- Madeo F, et al. Spermidine in health and disease. PubMed 29371440.
- Yousefzadeh MJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. PubMed 30279143.
- Reiten OK, et al. Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. PubMed 34517020.
- de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. PubMed 31881139.
- Holman RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes (UKPDS). PubMed 18784090.
- Kraus WE, et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE). PubMed 31303390.
- Kaeberlein M, Galvan V. Rapamycin and Alzheimer’s disease: Time for a clinical trial? PubMed 30674654.
- Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. PubMed 28068222.
- Johnson SC, et al. mTOR is a key modulator of ageing and age-related disease. PubMed 23325216.
- Campisi J, et al. From discoveries in ageing research to therapeutics for healthy ageing. PubMed 31292558.
- López-Otín C, et al. Hallmarks of aging: An expanding universe. PubMed 36599349.
- Verdin E. NAD+ in aging, metabolism, and neurodegeneration. PubMed 26785480.
- Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. PubMed 16732220.
- Lamming DW, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. PubMed 22461615.
- Blagosklonny MV. Rapamycin for longevity: opinion article. PubMed 31586989.
- Imai S, Guarente L. NAD+ and sirtuins in aging and disease. PubMed 24786309.
- Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. PubMed 29249689.